Investment
Features
FeesSafety
Academy
More
Pluang+

S&P 500 edges up, nearing August 2026 record amid Fed rate hike uncertainty and strong GDP growth forecast.

Market News
08 Sep 2026
Seeking Alpha
View Source
Neutral
S&P 500 edges up, nearing August 2026 record amid Fed rate hike uncertainty and strong GDP growth forecast.

The S&P 500 closed the final week of summer at 7,718.60, slightly higher than the previous week and just 1% below its record high set in August 2026. Investors are closely watching the upcoming fourth quarter of 2026, particularly due to uncertainty about whether the Federal Reserve will raise interest rates during that period. The Atlanta Fed's GDPNow tool forecasts a robust 4.7% real GDP growth for the U.S. economy in the third quarter of 2026, slightly up from the previous estimate of 4.6%. This economic outlook and Fed policy expectations are key factors influencing stock prices.

More News

ABM Industries beats Q3 EPS estimates with $1.04, posts record $2.3B revenue and strong cash flow.

ABM Industries beats Q3 EPS estimates with $1.04, posts record $2.3B revenue and strong cash flow.

ABM Industries reported strong Q3 2026 results, surpassing analyst EPS estimates with $1.04 per share versus the expected $1.01. The company achieved record revenue of $2.3 billion, a 4.2% increase driven by organic and acquisition growth. Adjusted n...

Company Fundamentals
Bullish
51 minutes ago
GameStop Q2 earnings show revenue drop but focus on strategic fund use and financial health.

GameStop Q2 earnings show revenue drop but focus on strategic fund use and financial health.

GameStop is set to report its Q2 2026 earnings with analysts expecting an EPS of $0.27 and revenues around $756.85 million, down from $972.20 million the previous year. The company’s own sales forecast of $780-$800 million confirms a significant reve...

Company Fundamentals
Neutral
54 minutes ago
Opus Genetics gets Buy rating ahead of key gene therapy data release on Sept 9, 2026.

Opus Genetics gets Buy rating ahead of key gene therapy data release on Sept 9, 2026.

Opus Genetics, a clinical-stage biotech focused on inherited retinal diseases, received a Buy rating and $8 price target from analyst Matthew Caufield in August 2026. The company plans to release topline Phase 1/2 data for its gene therapy OPGx-BEST1...

Analyst Insights
Bullish
1 hour ago
GE to acquire CPP for $11.75B, boosting aerospace casting capacity and earnings potential

GE to acquire CPP for $11.75B, boosting aerospace casting capacity and earnings potential

General Electric (GE) announced it will acquire Consolidated Precision Products (CPP) for $11.75 billion to enhance its aerospace casting production. This strategic move aims to strengthen GE's manufacturing capabilities and accelerate engine technol...

Analyst Insights
Bullish
1 hour ago
UNFI beats Q4 EPS estimates but misses revenue, expects growth ahead.

UNFI beats Q4 EPS estimates but misses revenue, expects growth ahead.

United Natural Foods, Inc. (UNFI) reported a Q4 adjusted EPS of $0.69, surpassing analyst expectations of $0.61, signaling strong profitability. However, revenue slightly missed estimates at $7.64 billion, down 0.7% from the previous year. Despite th...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App